Efficient Privacy-Preserving Identity Scheme for Electronic Validation of Phase 1 Clinical Trials

Conference paper

DOI: 10.1007/978-3-319-17957-5_12

Part of the Lecture Notes in Business Information Processing book series (LNBIP, volume 209)
Cite this paper as:
Farah H., Amyot D., Emam K.E. (2015) Efficient Privacy-Preserving Identity Scheme for Electronic Validation of Phase 1 Clinical Trials. In: Benyoucef M., Weiss M., Mili H. (eds) E-Technologies. MCETECH 2015. Lecture Notes in Business Information Processing, vol 209. Springer, Cham

Abstract

New drug studies are essential to advance the pharmaceutical industry’s ability to fight diseases. These studies are typically performed in four phases. We are interested in “phase 1” clinical trials where the goal is to evaluate the safety of a new drug. Contract research organizations recruit participants for their studies and need to verify electronically certain criteria without revealing the identity of these participants to other organizations. We outline some potential attacks against current identity representation schemes. Afterwards, we present privacy-preserving techniques to represent the identity of a participant in a scheme where operations can be performed efficiently and accurately. Our methods and scheme can also be applied to other domains to preserve an individual’s privacy.

Keywords

Identity Privacy Clinical trial E-health Cloud computing 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  1. 1.School of Electrical Engineering and Computer ScienceUniversity of OttawaOttawaCanada
  2. 2.Electronic Health Information LaboratoryChildren’s Hospital of Eastern Ontario Research InstituteOttawaCanada

Personalised recommendations